InsiderSignal.AI

InsiderSignal.ai

IONS - Ionis Pharmaceuticals Inc

Insider Sale by Devers Shannon L. (EVP, Chief HR Ofc)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Devers Shannon L., serving as EVP, Chief HR Ofc at Ionis Pharmaceuticals Inc (IONS), sold 6,193 shares at $74.05 per share, for a total transaction value of $458,613.00. Following this transaction, Devers Shannon L. now holds 16,348 shares of IONS.

This sale represents a 27.00% decrease in Devers Shannon L.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 2, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, April 2, 2026, meaning the disclosure happened on the same day as the trade.

Ionis Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Devers Shannon L.

EVP, Chief HR Ofc

Shannon L. Devers is an accomplished human resources executive serving as Executive Vice President and Chief Human Resources Officer at Ionis Pharmaceuticals Inc. (IONS), a role she has held after progressing through various HR positions since joining the company in February 2001 as a senior human resources manager.[[1]](https://www.biocom.org/people/shannon-devers/)[[2]](https://ionis.com/about-us/our-leadership) In 2020, her responsibilities expanded to include facilities as Senior Vice President of Human Resources & Facilities, overseeing talent management, compensation, benefits, employee relations, compliance, and campus operations, while shaping company culture, driving organizational change, fostering innovation, and promoting sustainability.[[1]](https://www.biocom.org/people/shannon-devers/)[[2]](https://ionis.com/about-us/our-leadership) Prior to Ionis, Devers gained HR experience at Target Corporation, Nike, Inc., and Taco Bell Corporation.[[1]](https://www.biocom.org/people/shannon-devers/)[[2]](https://ionis.com/about-us/our-leadership) She recently sold 44,199 shares of IONS common stock on January 7, 2026, under a trading plan.[[3]](https://www.sahmcapital.com/news/content/ionis-pharmaceuticals-evp-chief-human-resources-officer-shannon-l-devers-reports-sale-of-common-shares-2025-11-29)[[4]](https://www.tradingview.com/news/tradingview:b484fc975bf9d:0-ionis-pharmaceuticals-executive-sells-over-3-7-million-in-company-stock/) Devers holds an MBA in Human Resource Management and Marketing from the University of Florida and a BS in Business Administration (cum laude, Marketing focus) from the University of Central Florida.[[1]](https://www.biocom.org/people/shannon-devers/)[[2]](https://ionis.com/about-us/our-leadership) At 54 years old, she continues to contribute strategically to Ionis' growth in the competitive biotechnology sector.[[5]](https://www.morningstar.com/stocks/xmex/ions/executive)

View full insider profile →

Trade Price

$74.05

Quantity

6,193

Total Value

$458,613.00

Shares Owned

16,348

Trade Date

Thursday, April 2, 2026

3 days ago

SEC Filing Date

Thursday, April 2, 2026

HEALTHCAREBIOTECHNOLOGY

About Ionis Pharmaceuticals Inc

Company Overview

No company information available
View news mentioning IONS

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5328370

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime